lunes, 1 de agosto de 2016

Ebola Spotlight - Emerging Infectious Disease journal - CDC

Ebola Spotlight - Emerging Infectious Disease journal - CDC



Ebola Spotlight

Ebola Spotlight



Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strains. Ebola can cause disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees).
Ebola is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebola virus species, four of which are known to cause disease in humans. Ebola viruses are found in several African countries. Ebola was first discovered in 1976 near the Ebola River in what is now the Democratic Republic of the Congo. Before the current situation, outbreaks have appeared sporadically in Africa.
The natural reservoir host of Ebola virus remains unknown. However, on the basis of evidence and the nature of similar viruses, researchers believe that the virus is animal-borne and that bats are the most likely reservoir. Four of the five virus strains occur in an animal host native to Africa.
The Emerging Infectious Diseases journal has published many articles on Ebola. The journal published its first Ebola article in 1995, volume 1, issue number 3. Reemergence of Ebola Virus in Africa
Click on the links below to learn more about this important topic.

Articles

July 2106
Effective Chemical Inactivation of Ebola Virus
E. Haddock et al. (2016 Volume 22, Number 7)
June 2106
Perspectives on West Africa Ebola Virus Disease Outbreak, 2013–2016
J. R. Spengler et al. (2016 Volume 22, Number 6)
April 2016
Post-Ebola Syndrome, Sierra Leone
Janet T. Scott et al. (2016 Volume 22, Number 4)
March 2016
February 2016
Ebola and Its Control in Liberia, 2014–2015
T. G. Nyenswah et al. (2016 Volume 22, Number 2)
Prognostic Indicators for Ebola Patient Survival
S. J. Crowe et al. (2016 Volume 22, Number 2)
Ebola Virus Persistence in Semen Ex Vivo
R. J. Fischer et al. (2016 Volume 22, Number 2)
Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool
T. Hoenen et al. (2016 Volume 22, Number 2)
Initial Costs of Ebola Treatment Centers in the United States
J. J. Herstein et al. (2016 Volume 22, Number 2)
Responding to Ebola through Visual Poetry
B. Breedlove (2016 Volume 22, Number 2)
January 2016
November 2015
Ebola in West Africa—CDC’s Role in Epidemic Detection, Control, and Prevention 
T. R. Frieden and I. K. Damon (2015 Volume 21, Number 11)
Celebrating the Fabric of Commonplace Society 
B. Breedlove and N. M. M’ikanatha (2015 Volume 21, Number 11)
Liberia—Moving Beyond “Ebola Free” 
H. Keys et al. (2015 Volume 21, Number 11)
Etymologia: Ebola 
(2015 Volume 21, Number 11)
October 2015
August 2015
Transmission Models of Historical Ebola Outbreaks 
J. M. Drake et al. (2015 Volume 21, Number 8)
Human–Bat Interactions in Rural West Africa 
P. Anti et al. (2015 Volume 21, Number 8)
July 2015
Estimating Ebola Treatment Needs, United States 
G. Rainisch et al. (2015 Volume 21, Number 7)
June 2015
Ebola Risk Perception in Germany, 2014  
N. Rübsamen et al. (2015 Volume 21, Number 6)
May 2015
Ebola and Psychological Stress of Health Care Professionals 
M. Lehmann et al. (2015 Volume 21, Number 5)
April 2015
March 2015
Regional Spread of Ebola Virus, West Africa, 2014 
Rainisch G, et al. (2015 Volume 21, Number 3)
February 2015
2014
Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone 
Schoepp RJ, et al. (2014, Volume 20, Number 7)
2013
Ebola Virus Antibodies in Fruit Bats, Bangladesh 
Olival KJ, et al. (2013, Volume 19, Number 2)
2012
Reemerging Sudan Ebola Virus Disease in Uganda, 2011 
Shoemaker T, et al. (2012, Volume 18, Number 9)
Ebola Virus Antibodies in Fruit Bats, Ghana, West Africa 
Hayman DTS, et al. (2012, Volume 18, Number 7)
2011
Reston Ebolavirus Antibodies in Bats, the Philippines  
Taniguchi S, et al. (2011, Volume 17, Number 8)
2010
2009
Immunoglobulin G in Ebola Outbreak Survivors, Gabon 
Wauquier N et al. (2009, Volume 15, Number 7)
2008
2005
Ebola Virus Antibody Prevalence in Dogs and Human Risk 
Allela L, et al. (2005, Volume 11, Number 3)
Pygmy Populations Seronegative for Marburg Virus 
Borchert M, et al. (2005, Volume 11, Number 1)
2004
Infectious Diseases and Maternal Morbidity and Mortality 
Finnegan LP, et al. (2004, Volume 10, Number 11)
New and Emerging Zoonoses 
Pappaioanou M, et al. (2004, Volume 10, Number 11)
Ecologic and Geographic Distribution of Filovirus Disease 
Peterson AT, et al. (2004, Volume 10, Number 1)
2003
Cultural Contexts of Ebola in Northern Uganda 
Hewlett BS and Amola RP. (2003, Volume 9, Number 10)
2002
Ebola-Poe: A Modern-Day Parallel of the Red Death? 
Vora SK and Ramanan SV. (2002, Volume 8, Number 12)
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus 
Geisbert TW, et al. (2002, Volume 8, Number 5)
1999
Risk for Ebola Virus Infection in Côte d'Ivoire 
Kunii O, et al. (1999, Volume 5, Number 2)
1998
Ebola/Athens Revisited 
Olson PE, et al. (1998, Volume 4, Number 1)
1997
Immunostaining of Ebola Virus Antigens 
Zaki SR. (1997, Volume 3, Number 1)
1996
Experimental Inoculation of Plants and Animals with Ebola Virus 
Swanepoel SR, et al. (1996, Volume 2, Number 4)
DNA Vaccines for Emerging Infectious Diseases: What If? 
Whalen RG. (1996, Volume 2, Number 3)
The Thucydides Syndrome: Ebola Déjà Vu? (or Ebola Reemergent?) 
Olson PE, et al. (1996, Volume 2, Number 2)
1995
Reemergence of Ebola Virus in Africa 
Sanchez A, et al. (1995, Volume 1, Number 3)

Podcasts

Additional Resources

No hay comentarios:

Publicar un comentario